These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 28867440)

  • 1. Etonogestrel implant migration to the vasculature, chest wall, and distant body sites: cases from a pharmacovigilance database.
    Kang S; Niak A; Gada N; Brinker A; Jones SC
    Contraception; 2017 Dec; 96(6):439-445. PubMed ID: 28867440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A French survey of contraceptive implant migration to the pulmonary artery.
    Ohannessian A; Levy A; Jaillant N; Tanguy Le Gac Y; D'Journo X; Vidal V; Agostini A
    Contraception; 2019 Oct; 100(4):255-257. PubMed ID: 31194964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Safety profile of etonogestrel contraceptive implant (Nexplanon
    Simon C; Agier MS; Béné J; Muller C; Vrignaud L; Marret H; Jonville-Bera AP
    J Gynecol Obstet Biol Reprod (Paris); 2016 Nov; 45(9):1074-1082. PubMed ID: 27125380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of immediate postpartum compared to delayed postpartum and interval etonogestrel contraceptive implant insertion on removal rates for bleeding.
    Ireland LD; Goyal V; Raker CA; Murray A; Allen RH
    Contraception; 2014 Sep; 90(3):253-8. PubMed ID: 24973904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allergic and infectious complications of Etonogestrel implant placements: A case series.
    Osterbur Badhey ML; Li S; Alimena S; Johnson NR; Bartz D
    Contraception; 2023 Jun; 122():109994. PubMed ID: 36871621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The US etonogestrel implant mandatory clinical training and active monitoring programs: 6-year experience.
    Creinin MD; Kaunitz AM; Darney PD; Schwartz L; Hampton T; Gordon K; Rekers H
    Contraception; 2017 Feb; 95(2):205-210. PubMed ID: 27452317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Etonogestrel implant migration into the pulmonary artery.
    Clermidy H; Fabre D; Hugues JN; Alonso CG; Mitilian D; Mercier O; Brenot P; Charbonneau P; Fadel E
    Contraception; 2022 Sep; 113():62-67. PubMed ID: 35351447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and characteristics of intravascular pulmonary migration of etonogestrel implants: A French nationwide study.
    Simon C; Maurier A; Gaboriau L; Vrignaud L; Dayani P; Vaillant T; Andrée Bos-Thompson M; Jonville-Bera AP
    Contraception; 2020 Sep; 102(3):186-189. PubMed ID: 32417204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravascular migration of contraceptive implants: two more cases.
    Rowlands S; Mansour D; Walling M
    Contraception; 2017 Feb; 95(2):211-214. PubMed ID: 27452318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bleeding related to etonogestrel subdermal implant in a US population.
    Casey PM; Long ME; Marnach ML; Bury JE
    Contraception; 2011 May; 83(5):426-30. PubMed ID: 21477684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Immediate Postpartum Etonogestrel Implant Insertion and Venous Thromboembolism.
    Floyd JL; Beasley AD; Swaim LS; Turrentine MA; Nijjar JB
    Obstet Gynecol; 2020 Jun; 135(6):1275-1280. PubMed ID: 32459418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etonogestrel contraceptive implant-associated secondary anorgasmia.
    Chapa HO; Ramirez A; Dawson D
    Contraception; 2017 Oct; 96(4):254-256. PubMed ID: 28666796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immediate versus delayed insertion of an etonogestrel releasing implant at medical abortion-a randomized controlled equivalence trial.
    Hognert H; Kopp Kallner H; Cameron S; Nyrelli C; Jawad I; Heller R; Aronsson A; Lindh I; Benson L; Gemzell-Danielsson K
    Hum Reprod; 2016 Nov; 31(11):2484-2490. PubMed ID: 27664217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged use of the etonogestrel implant and levonorgestrel intrauterine device: 2 years beyond Food and Drug Administration-approved duration.
    McNicholas C; Swor E; Wan L; Peipert JF
    Am J Obstet Gynecol; 2017 Jun; 216(6):586.e1-586.e6. PubMed ID: 28147241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real world data on Nexplanon® procedure-related events: final results from the Nexplanon Observational Risk Assessment study (NORA).
    Reed S; Do Minh T; Lange JA; Koro C; Fox M; Heinemann K
    Contraception; 2019 Jul; 100(1):31-36. PubMed ID: 30980829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Migration of a subdermal contraceptive implant into a subsegmental pulmonary artery and etonogestrel serum concentration over time - a case report.
    Kafi Mallak F; Kopp Kallner H
    Eur J Contracept Reprod Health Care; 2022 Jun; 27(3):261-264. PubMed ID: 35174737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early removal of etonogestrel subcutaneous contraceptive implant at a community health centre in Pretoria.
    Moeti DMP; Govender I; Bongongo T
    S Afr Fam Pract (2004); 2022 Jul; 64(1):e1-e6. PubMed ID: 35924618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Migration of contraceptive implant into the left pulmonary arterial system.
    Kew EP; Senanayake E; Djearaman M; Bishay E
    Asian Cardiovasc Thorac Ann; 2017; 25(7-8):537-539. PubMed ID: 28605952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 3-year multicentre randomized controlled trial of etonogestrel- and levonorgestrel-releasing contraceptive implants, with non-randomized matched copper-intrauterine device controls.
    Bahamondes L; Brache V; Meirik O; Ali M; Habib N; Landoulsi S;
    Hum Reprod; 2015 Nov; 30(11):2527-38. PubMed ID: 26409014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etonogestrel contraceptive implant: ulnar nerve damage.
    Prescrire Int; 2008 Apr; 17(94):63. PubMed ID: 18516815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.